Since 2009, OIS has set the benchmark for excellence in eye care innovation by uniting pioneering startups, leading strategics, top investors, and renowned clinicians. More than a conference, OIS is a trusted community where ideas take root, partnerships are born, and the future of ophthalmology is shaped. With expertly curated programming, exclusive networking opportunities, and unmatched access to breakthrough technologies, OIS empowers industry leaders to make impactful decisions and build relationships that last.

For over 15 years, it has been the catalyst for game-changing therapies and meaningful collaboration driven by a deep commitment to authenticity, community, and the belief that extraordinary things happen when the right people connect.

SUBSCRIBE TO THE OIS WEEKLY NEWSLETTER 

Don't miss exclusive content, latest news, special promotions, and more! Join the OIS Community and subscribe to the Weekly Newsletter below.

Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.

OIS XIV Testimonials

Susan Benton Headshot

Susan Benton

President - i2eye Consulting LLC

The OIS meeting is one of the most relevant and best forums for bringing together all stakeholders involved in ophthalmic innovation. The program delivers quality content from a diverse group of experts across both the pharmaceutical and med device spaces. This is a must attend program for anyone who is developing tomorrow's innovation today.

David Killengray Headshot (1)

David Killengray

Chief Commercial Officer - Medevise Consulting

OIS represents a great opportunity to see the coming developments in ophthalmology, delivered by innovators. There is a real opportunity to learn about the issues affecting startups and the process of getting an idea realized into a product and beyond.

Veysel Ozkapici Headshot

Veysel Ozkapici

CEO - GlaucoT

Participating in OIS XIV was an exceptional experience for GlaucoT. The conference provided a unique platform to showcase our innovative solutions for glaucoma management, including our groundbreaking wearable neuroprotective system and the novel mobile camera-based intraocular pressure measurement technology. Engaging with leading experts, investors, and strategic partners in the ophthalmology space was invaluable. The insightful discussions and feedback we received have further fueled our mission to revolutionize glaucoma treatment. We are grateful for the opportunity to connect with such a vibrant and forward-thinking community and look forward to continuing our journey with the momentum gained from OIS XIV.

Sanjeev Ganatra Headshot

Sanjeev Ganatra

Global Head, Ophthalmology - CBCC Global Research

OIS continues to be true to its name as the Ophthalmic Innovation Source. A source for early companies to have a friendly and welcoming on ramp into eye care and a source for investors and strategic companies to be introduced to and evaluate the next generation of innovators and innovations.

James Murrey HeadShot

James Murray

Managing Partner - ExSight Ventures

OIS continues to be a must attend event for anyone in the ophthalmology space. The organizers curate an ever evolving slate of discussions that reflect the market and set the tone for the next year.

Jeroen Wissink HeadShot

Jeroen Wissink

CEO - Uneedle

This is networking to the max.

SUBSCRIBE TO THE OIS WEEKLY NEWSLETTER 

Don't miss exclusive content, latest news, special promotions, and more! Join the OIS Community and subscribe to the Weekly Newsletter below.

Please enter your name.
Please enter a valid email address.
Something went wrong. Please check your entries and try again.